Brain and Mind Research Institute

  • Description
  • About us

    Dis­eases of the brain and mind, includ­ing sub­stance abuse, clin­i­cal depres­sion and demen­tia now account for more than 40 per­cent of all illness.

    These dis­eases are dev­as­tat­ing for those affected, their fam­i­lies, and for soci­ety; cost­ing the Aus­tralian econ­omy an esti­mated $30 bil­lion each year.

    Up to 1.6 mil­lion Aus­tralians, 8 per cent of the pop­u­la­tion, are either per­ma­nently or tran­siently affected by depres­sion or other men­tal ill­nesses dur­ing the course of a year, and about 60 per­cent are not receiv­ing stan­dard treatments.

    The chal­lenge remains to tackle and lower the inci­dence of men­tal ill­ness in all its forms, includ­ing depres­sion, anx­i­ety, sub­stance abuse, schiz­o­phre­nia and bipo­lar dis­or­der and demen­tias such as Alzheimer’s dis­ease. We need new insights and treat­ments that arise from active research and clin­i­cal collaboration.

    The Brain & Mind Research Insti­tute (BMRI) has a fun­da­men­tal com­mit­ment to the long-​neglected areas of brain and mind dis­or­ders, pur­su­ing gen­uine part­ner­ships with the wider com­mu­nity as a vital part of our research and activities.

    In August 2010, the NSW gov­ern­ment com­mit­ted $25m in addi­tion to a $15m con­tri­bu­tion by the Uni­ver­sity of Syd­ney for the con­struc­tion of a new Men­tal Health facil­ity con­tain­ing a ded­i­cated in-​patient research facil­ity. The BMRI has part­nered with the Local Health Dis­trict to estab­lish a new Men­tal Health Hos­pi­tal to replace the Mis­senden Unit. The new hos­pi­tal will be located in close prox­im­ity to the BMRI and is sched­uled to open in 2014.

    The syn­er­gies that arise from the shar­ing of unique facil­i­ties and the active inter­mix­ing of senior researchers from the basic and clin­i­cal neu­ro­sciences pro­motes new research dis­cov­er­ies into dis­or­ders of the brain and mind, pro­vid­ing hope for those indi­vid­u­als and fam­i­lies whose lives are dev­as­tated by these conditions.

    Get involved

    BMRI Philosophy

    Our key phi­los­o­phy is that few med­ical dis­cov­er­ies are made in iso­la­tion and that new solu­tions require col­lab­o­ra­tion, a clear com­mon pur­pose and an active dia­logue with the wider community.

    BMRI Goals

    • To be the lead­ing site in Aus­tralia for pro­vi­sion of expert clin­i­cal assess­ment, inves­ti­ga­tion and inno­v­a­tive treat­ments for com­mon brain and mind disorders.
    • To develop new pro­ce­dures, tech­nolo­gies or med­i­cines that result in the pre­ven­tion or cure of dis­abling brain and mind disorders.

    Our Research

    Neu­ro­science

    Under­stand­ing behav­ioural neu­ro­science, devel­op­men­tal neu­ro­bi­ol­ogy and genomics, neu­ropsy­chi­a­try, brain tumours, and neuro-​otology.

    Brain Imag­ing

    Devel­op­ing novel bio­mark­ers and non-​invasive imag­ing tech­nolo­gies to aid drug dis­cov­ery, imag­ing physics, BMRI 3T MRI, phar­ma­col­ogy, neu­ro­bi­ol­ogy and psy­chi­a­try.

    Demen­tia

    Inves­ti­gat­ing the mech­a­nisms under­ly­ing Alzheimer’s and Parkinson’s dis­ease, Alzheimer’s cell biol­ogy, Regen­er­a­tive neu­ro­science and mol­e­c­u­lar neu­ro­science.

    Devel­op­men­tal Dis­or­ders

    Pro­vid­ing care to chil­dren suf­fer­ing from autism, down syn­drome, atten­tion deficit hyper­ac­tiv­ity dis­or­der and other dis­or­ders of the brain and mind.

    Men­tal Health

    Deliv­er­ing clin­i­cal ser­vices in psy­chi­a­try, neu­rol­ogy and pop­u­la­tion men­tal health, includ­ing clin­i­cal research, e-​health, youth men­tal health pro­grams, head­space, pub­lic pol­icy, smok­ing ces­sa­tion, and vet­eran fam­ily health.

    Mul­ti­ple Scle­ro­sis

    Research activ­i­ties include chronic and acute pain, clin­i­cal tri­als, and inflam­ma­tory neu­ropathies.

    Schiz­o­phre­nia

    Study­ing phar­ma­coepi­demi­ol­ogy, clin­i­cal phar­ma­col­ogy antipsy­chotics, risk ben­e­fits and applied clin­i­cal phar­ma­col­ogy of antipsy­chotic switch­ing, and phys­i­cal comorbidities.


    Details

    Phone +61.2.93.51-0799

    Social Networks and Comments